Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,522 | 214 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,062 | 125 | $0 (2021) |
| Abbott Laboratories | $947.74 | 9 | $0 (2018) |
| Novo Nordisk Inc | $918.10 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $625.02 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $538.94 | 8 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $491.52 | 4 | $0 (2023) |
| Lilly USA, LLC | $189.46 | 6 | $0 (2022) |
| ABIOMED | $132.24 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $84.10 | 5 | $0 (2023) |
| AbbVie Inc. | $56.25 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.07 | 6 | AstraZeneca Pharmaceuticals LP ($124.98) |
| 2023 | $742.23 | 12 | AstraZeneca Pharmaceuticals LP ($256.82) |
| 2022 | $533.50 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($244.22) |
| 2021 | $370.24 | 11 | GlaxoSmithKline, LLC. ($133.82) |
| 2020 | $87.55 | 5 | Sunovion Pharmaceuticals Inc. ($47.55) |
| 2019 | $212.85 | 13 | Novo Nordisk Inc ($117.84) |
| 2018 | $1,311 | 84 | Abbott Laboratories ($596.80) |
| 2017 | $1,945 | 75 | Novo Nordisk Inc ($566.79) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $117.71 | General |
| 08/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Oncology | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.39 | General |
| 10/03/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.26 | General |
| Category: Respiratory | ||||||
| 05/24/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/05/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $132.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.68 | General |
| 04/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $122.30 | General |
| Category: Cardio-renal | ||||||
| 01/11/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 01/04/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Rare Disease | ||||||
| 12/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.92 | General |
| Category: Cardio-renal | ||||||
| 10/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $122.30 | General |
| 10/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 368 | 2,116 | $340,496 | $179,491 |
| 2022 | 10 | 411 | 2,440 | $363,764 | $185,418 |
| 2021 | 9 | 364 | 2,464 | $351,358 | $188,619 |
| 2020 | 9 | 453 | 3,218 | $445,640 | $234,624 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 734 | $138,876 | $74,286 | 53.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 103 | 797 | $95,424 | $50,748 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 143 | $29,917 | $15,096 | 50.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 219 | $27,445 | $14,812 | 54.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 69 | $19,186 | $9,727 | 50.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 37 | 47 | $13,715 | $7,347 | 53.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 43 | 88 | $15,074 | $7,314 | 48.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 19 | $860.00 | $159.60 | 18.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 845 | $141,345 | $73,782 | 52.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 717 | $83,592 | $43,761 | 52.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 77 | 565 | $65,183 | $32,798 | 50.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 69 | 115 | $37,323 | $19,328 | 51.8% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 38 | 41 | $11,137 | $5,690 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 50 | $7,068 | $3,024 | 42.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 15 | 37 | $6,125 | $2,408 | 39.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 20 | $4,413 | $2,310 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 33 | $6,727 | $2,266 | 33.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 17 | $850.00 | $50.67 | 6.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 56 | 621 | $105,607 | $56,357 | 53.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 871 | $102,512 | $55,246 | 53.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 85 | 659 | $75,482 | $40,115 | 53.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 53 | 98 | $32,498 | $17,366 | 53.4% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 41 | 52 | $14,187 | $7,662 | 54.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 92 | $11,261 | $7,061 | 62.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 23 | 37 | $5,581 | $3,020 | 54.1% |
About Dr. Robert Clarke, MD
Dr. Robert Clarke, MD is a Internal Medicine healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114934007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Clarke, MD has received a total of $5,522 in payments from pharmaceutical and medical device companies, with $319.07 received in 2024. These payments were reported across 214 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,522).
As a Medicare-enrolled provider, Clarke has provided services to 1,596 Medicare beneficiaries, totaling 10,238 services with total Medicare billing of $788,152. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location East Orange, NJ
- Active Since 08/02/2006
- Last Updated 01/08/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114934007
Products in Payments
- LATUDA (Drug) $600.74
- CRT-Ds (Device) $494.59
- Kerendia (Drug) $369.22
- FARXIGA (Drug) $277.19
- ANORO ELLIPTA (Drug) $236.05
- Tresiba (Drug) $217.92
- Xultophy 100/3.6 (Drug) $216.71
- APTIOM (Drug) $182.14
- BEVESPI AEROSPHERE (Drug) $175.78
- Fortify Assura, Ellipse ICD (Device) $170.82
- TRELEGY ELLIPTA (Drug) $146.63
- JARDIANCE (Drug) $143.73
- Impella (Device) $132.24
- Saxenda (Drug) $125.00
- Victoza (Drug) $125.00
- BREZTRI (Drug) $116.26
- Ozempic (Drug) $115.76
- ICDs (Device) $106.16
- Quadra Assura CRT Defibrillator (Device) $101.86
- LONHALA MAGNAIR (Drug) $97.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Orange
Dr. Alexander Salerno, Md, MD
Internal Medicine — Payments: $73,770
Dr. Gitendra Rajiyah, Md, MD
Internal Medicine — Payments: $20,111
Eddy Simon, Md, MD
Internal Medicine — Payments: $7,943
Dr. Anand Srinivasan, Md, MD
Internal Medicine — Payments: $7,905
Dr. Radhika Maddali, Md, MD
Internal Medicine — Payments: $6,737
Dr. Mamatha Mohan, M.d, M.D
Internal Medicine — Payments: $6,050